Jeff Leek

Seattle, Washington, U.S.

Jeff Leek is Co-founder and Chief Data Officer at Fred Hutchinson Cancer Center, where he continues to serve.

Fred Hutch-Led Synthesize Bio Raises $10M to Accelerate Drug Discovery Using AI Gene Expression Model

Seattle-based Synthesize Bio, led by Fred Hutchinson Cancer Center researchers, raised $10 million from Madrona to accelerate drug discovery using their AI model GEM-1, which predicts gene expression outcomes with lab-level accuracy. The startup aims to reduce drug development time and costs by simulating hypothetical lab experiments with generative genomics.

Leading $10M Seed Funding Supports Synthesize Bio's AI-Powered GEM-1 Model Transforming Generative Genomics

The future of biotech is being shaped by AI-powered reasoning machines, exemplified by Synthesize Bio's $10M Seed funding led to develop GEM-1, a generative genomics model simulating gene expression as accurately as lab experiments. This technology enables researchers to conduct more innovative and cost-effective life science R&D, moving from bottlenecks to breakthroughs.

Organizations